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ABSTRACT: When using biosensors, analyte biomolecules of
several different concentrations are percolated over a chip with
immobilized ligand molecules that form complexes with
analytes. However, in many cases of biological interest, e.g.,
in antibody interactions, complex formation steady-state is not
reached. The data measured are so-called sensorgram, one for
each analyte concentration, with total complex concentration
vs time. Here we present a new four-step strategy for more
reliable processing of this complex kinetic binding data and
compare it with the standard global fitting procedure. In our
strategy, we first calculate a dissociation graph to reveal if there
are any heterogeneous interactions. Thereafter, a new
numerical algorithm, AIDA, is used to get the number of
different complex formation reactions for each analyte concentration level. This information is then used to estimate the
corresponding complex formation rate constants by fitting to the measured sensorgram one by one. Finally, all estimated rate
constants are plotted and clustered, where each cluster represents a complex formation. Synthetic and experimental data obtained
from three different QCM biosensor experimental systems having fast (close to steady-state), moderate, and slow kinetics (far
from steady-state) were evaluated using the four-step strategy and standard global fitting. The new strategy allowed us to more
reliably estimate the number of different complex formations, especially for cases of complex and slow dissociation kinetics.
Moreover, the new strategy proved to be more robust as it enables one to handle system drift, i.e., data from biosensor chips that
deteriorate over time.
Biological medicines, such as peptides, proteins, mRNA,oligonucleotides, vaccines, and plasmids,1−4 are a strongly
growing area of importance for the pharmaceutical industry.5,6
Reliable analysis of biomolecular interactions is crucial in order
to fulfill modern drug quality assurance criteria, both for
traditional small API molecules7 and for next-generation
biological drugs. Therefore, there has been an accelerated
technological development of biosensor instruments based on,
among others, surface plasmon resonance (SPR) and quartz
crystal microbalance (QCM).8−10
The interaction data from Bbiosensor instruments is nearly
always processed using a simple model fitting procedure
assuming just one, or sometimes two, distinct interactions
(complex formation reactions) with or without mass transport
limitations.8,11−15 In a global benchmarking study, 150
participants from 20 different countries were provided with
aliquots of two binding partners (a 50-kDa Fab and a 60-kDa
glutathione S-transferase [GST]-tagged Ag) that form a relative
high affinity complex.11 The participants were asked to
determine the rate constants for the interaction. The majority
of the participants fitted the data to a simple or mass-transport
limited one-to-one model. Only four of the participants fitted to
a two-to-one interaction model.11 The authors speculated that
more advanced models were applied to compensate for
nonspecific interactions. Other studies12,13 suggest that experi-
ments should be redone using, e.g., alternative immobilization
techniques if one-to-one model does not fit well. Applying
models that are more complex is not preferred, and one should
“go back and redesign the experiment to improve the quality of
the data”.12 In some extreme cases, data that do not fit the
model are excluded.16 Rich et al. state that a more complex
model fits always better, “simply because it f its better does not
mean it is correct”,12 which, of course, is true. The use of a more
complex model will result in a better model fit, but it will not
necessarily reveal the system’s true mechanistic behavior.
However, it is also true that if a more complex model fits the
data better, it will more accurately describe the system’s
behavior during the studied time range, even if the more
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complex model does not reflect the system’s true mechanistic
behavior it will be a very accurate model of it. As biological
systems are indeed complex, it is very risky to use only the
simplest kinetic model regardless of how well it fits the data.
Regardless of the model, if the model fit is poor it does not
describe the system accurately.
If the complex formation reactions are sufficiently fast to
reach steady-state, one way to accurately estimate the number
of interactions is to use a three-step approach based on an
algorithm called Adsorption Energy Distribution (AED)
calculations.17,18 This approach has been used for adsorption
studies in several publications, both for SPR19 and QCM20,21
biosensors. However, AED has limited use for biosensor data
since steady state, which is rarely reached in most biological
biosensor applications of interest, is required. Therefore, a
numerical tool similar to AED, called Rate Constant
Distribution (RCD) or Interaction Maps,22−24 has been
developed for biosensor data. Using RCD calculations, one
gets the number of interactions needed to describe the system,
and their associated rate constants, as peaks on a surface.
However, RCD calculations are not usually part of biosensor
instruments software, and the implementations that do exist
take up to days to calculate a single RCD.23 Our new Adaptive
Interaction Distribution Algorithm (AIDA)25 does not only
give higher resolution since it adapts to the solution, but it is
also fast, the calculations take only a few seconds, and thereby
allows RCDs to be used as a standard tool.
The aim of this study is to introduce and evaluate a new four-
step strategy, based on our new numerical algorithm AIDA, for
more reliable analysis of interaction data. Verification will be
done using both synthetic and experimental data obtained from
three different experimental systems exhibiting fast to slow
interactions. The new strategy will also be compared to the
conventional method, i.e., to simultaneously fit a one or two-
site kinetic model to all sensorgrams, so-called global fitting.
This four-step strategy can also be applied to the clarification of
interactions between biomolecules and cell surfaces, present in
a very complex and biologically relevant environment where a
more complex fitting model is often needed.
■ THEORETICAL SECTION
For a more detailed description of the theory, see the
Supporting Information. Here we will assume that we have a
biosensor system where the kinetics is described by an “n-to-
one” model, i.e., we have n interactions of the following type,
+ ⇌[A ] [L] [A L]i
k
k
i
i
i
d,
a,
(1)
Figure 1. (a) Sensorgrams for a deteriorating synthetic system at different analyte concentration levels; vertical line indicates injection duration. (b)
Dissociation graph for a 220 nM injection. (c) Rate Constants Distribution (RCD) for a 24 nM injection. (d) Rate constants obtained by fitting a
two interactions model to the sensorgrams one by one. In part d, the circled areas are proportional to the relative contributions, the crosses indicate
median rate constants, and the stars are the estimated rate constants from global fitting to a two interactions model. See the Supporting Information
Table S1 for rate constants.
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in the system. Here [Ai] is an injected analyte, [L] is a ligand
immobilized on the biosensor chip surface, [AiL] is a complex
formed between the analyte and the ligand, and this reaction
has the corresponding association and disassociation rate
constants, ka,i and kd,i, respectively.
If we have n different interactions in the system of the type in
eq 1, the total response of the system will be the sum of the
individual responses of the interactions. Here we define the
contribution ci of interaction i to the total response as the mean
of the interaction’s relative contribution to the association and
dissociation phase.
In a practical situation, we want to estimate the rate
constants ka,i, kd,i from experimental sensorgram data. This is
usually done by fitting all experimental sensorgrams simulta-
neously to a model with one, or perhaps two, interaction(s) of
the type in eq 1. Assuming the “n-to-one” kinetic model in eq 1,
a useful simple tool that indicates if one has one or more
interactions in the biosensor system is the dissociation graph.
Here ln[R(t)/R0] is plotted against t for the dissociation phase,
R(t) is the response at time t, and R0 is the response at the start
of the dissociation phase. If the resulting curve is near the top-
left to bottom-right diagonal, then there is only one interaction
in the system, but if it is convex, then there are at least two
different interactions in the system. Note that only the shape of
the graph is important, so for the clarity of presentation, axis
numbering is omitted here, see for example Figure 1b.
It is well-known that the assumption of a “n-to-one” kinetic
model might not hold in some cases. For example, Ogi et al.
have studied the effect of flow rate on determined rate
constants between human IgG and protein A.26 They found
that an increase of the flow rate 20 times lead to an increase, in
both the association and dissociation rate constant, with a factor
of three. However, our proposed strategy can be used as an
accurate representation of a wide range of different systems,
regardless of the true underlying interactions. In a similar way
as any measured signal can be represented with a Fourier series
expansion, whatever the true underlying process(es) that
generates the signal are.
Rate Constant Distributions. If we let the number of
interactions in the system → ∞, assuming interactions of the
type in eq 1, the total response of the system can be modeled
by an inhomogeneous Fredholm Integral Equation of the first
kind. One can estimate a so-called Rate Constant Distribution
(RCD) by solving the corresponding inverse Integral Equation
problem using an algorithm called AIDA, developed by us.25 In
an RCD we have the interaction contribution vs the rate
constants ka and kd, see for example Figure 1. An RCD consists
of a number of discrete distributions, and the mode of these
distributions can be viewed as estimates of the biosensor
systems rate constants.
Calculation of RCDs using AIDA25 is considerably faster
than fitting to the experimental data, and here we do not have
to select the number of interactions in the system. However,
RCDs should be used with caution, as they are the solution of
an ill-posed and ill-conditioned inverse problem, and the
solution depends heavily on the amount and type of
regularization applied. One generally needs to use several
sensorgrams when calculating an RCD in order to get reliable
results and a good advice is to check the results by also doing
model fitting. When using several sensorgrams, and proper
regularization, one can get a good estimate of number of
interactions and their corresponding rate constants from the
peak maxima. These can, for example, be used as input to the
fitting algorithm, but one should never try to draw any
conclusions about the system from the peak shapes.
In the proposed strategy, we will calculate RCDs separately
for each sensorgram, and the resulting RCDs can be used as a
guide to decide the number of interactions and their rate
constants.
■ EXPERIMENTAL SECTION
Chemicals and Materials. Trastuzumab (Mw 145531.5 g/
mol) (Roche, Basel, Switzerland), purified recombinant human
epidermal growth factor receptor 2 (HER2) (R&D Systems
Europe Ltd., Abingdon, United Kingdom), parathyroid
hormone (1-34) (PTH) (Mw 4117.75 g/mol) (Tocris
Bioscience, Bristol, U.K.), and Human PTH1 receptor with a
His-tag (NovoPro, Shanghai, China) was used. Zeba spin
desalting column from Thermo Fisher Scientific, was used to
for the buffer exchange of trastuzumab. Other chemicals were
purchased from Sigma-Aldrich unless noted otherwise. Hydro-
chloric acid (0.1−1.0 M) and sodium hydroxide (0.1−1.0 M)
were obtained from Oy FF-Chemicals (Yli-Ii, Finland).
Phosphoric acid was from Merck (Darmstadt, Germany).
Ammonia (25%) was purchased from Riedel-de Haen̈ (Seelze,
Germany). NaCl was from Fisher Chemicals (Loughborough,
U.K.). Ethylenediaminetetraacetic acid disodium salt dihydrate
(Na2EDTA), bovine serum albumin (BSA), sodium citrate
trihydrate, and sodium azide were from Sigma Chemicals Co.
(St. Louis, MO). Gentamycin sulfate (BioReagent, suitable for
cell culture) was from Lonza (Basel, Switzerland). Sulfo-N-
hydroxy-succinimide (S-NHS, 98.0%) and 1-ethyl-3-(3-
(dimethylamino)propyl) carbodiimide hydrochloride (EDC-
HCl, 98.5%) were purchased from Aladin Chemical Reagent
Company (Shanghai, China). The water used in the experi-
ments was purified in a Milli-Q system (Millipore AB, Billerica,
MA) and a Millipore water purification system (Millipore,
Molsheim, France). Intermediate-Density Lipoprotein (IDL)-
Very Low-Density Lipoprotein (VLDL) and antihuman apoB-
100 (anti-apoB-100) monoclonal antibody (Mab) were
produced according to ref 27. Molar concentrations of IDL-
VLDL were calculated using the molecular weight of apoB-100
(512000 g/mol).
The Attana Cell 200 (Attana AB, Stockholm, Sweden) QCM
Biosensor was used for the trastuzumab-HER2 and PTH-
PTH1R experimental analyses. The Attana A100 instrument
(Attana AB, Stockholm, Sweden) was used for the IDL-VLDL-
anti-apoB-100 Mab experimental analyses.
The fundamental frequency of the crystals in this study was
around 10 MHz in thickness shear mode. The immobilized
protein constitutes a rigid layer and is suitable for the following
kinetic measurement. Thus, the Sauerbrey equation28 should
give a good approximation for correlating sensor response to
adsorbed amount of solute; in other words, the sensor signal is
proportional to the adsorbed amount of solute on the chip.
Sensor Procedures. Synthetic Assay. For the synthetic
data we used a system with two interactions and rate constants
log10(ka,1) = 6.00 (M s)
−1, log10(kd,1) = −2.50 s−1, log10(ka,2) =
4.50 (M s)−1, log10(kd,2) = −1.50 s−1 with Rmax,1 = 100.0 RU,
Rmax,2 = 500.0 RU. We made 10 injections with concentrations
C = 5, 13, 24, 37, 55, 77, 105, 137, 175, and 220 nM, and the
injection time was 100 s and the run time was 600 s. To
simulate a deteriorating system, Rmax was set to 95% of the
value in the previous injection.
HER2 Assay. HER2 was amine coupled to a LNB-carboxyl
chip using the manufactures’ amine coupling kit and protocol
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(Attana AB, Stockholm, Sweden). In brief, 10 mM HEPES, 150
mM NaCl, 0.005% Tween-20, pH 7.4, was used as
immobilization buffer. Carboxyl groups on the chip surface
were activated by a 50 μL injection of 0.2 M EDC and 0.05 M
S-NHS. A volume of 50 μL of HER2 (5 μg/mL diluted in 10
mM acetic acid, pH 4.5) was injected over the activated surface
at a flow rate of 10 μL/min. The frequency change was typically
between 20 and 30 Hz. Finally, free carboxyl groups were
blocked by a 50 μL injection of 1 M ethanolamine pH 8.5.
The adsorption data for trastuzumab at 35 °C were acquired
by 35 μL of trastuzumab (1, 2, 4, 8, 12, 18, and 25 μg/mL) at a
flow rate of 20 μL/min. Following dissociation for 300 s the
surface was regenerated with a 6 μL injection of 10 mM glycine
pH 2.0 (Acros Organics, Fisher Scientific) and re-equilibrated
with running buffer (phosphate buffered saline (PBS), pH 7.4,
Giboc, Fisher Scientific). Blank injections were performed prior
to every analyte injection, see Figure S1 in the Supporting
Information, and after each analyte injections, the loops were
washed with 100 mM acetic acid and repeated washes of
running buffer.
Anti-ApoB-100 Assay. Anti-apoB-100 Mab was immobilized
onto LNB-carboxyl chip (Attana AB, Stockholm, Sweden)
using amine coupling according to the protocol described in a
previous study.27 In brief, the chip was prewetted ex situ with 20
μL of Milli-Q and left to stabilize in the instrument. The
immobilization was performed at the flow rate 10 μL/min
under 25 °C with 10 mM HEPES, 150 mM NaCl, 0.005%
Tween 20, pH 7.4, as the immobilization buffer. The surface
was activated once by injecting 50 μL of freshly mixed 0.4 M
EDC and 0.1 M S-NHS (1:1, v/v). Followed by two injections
(50 μL each) of anti-apoB-100 Mab (100 μg/mL in phosphate
buffer; pH 6.4). The frequency change was typically between 30
and 60 Hz. Deactivation was done with two injections (50 μL)
of 1 M ethanolamine solution (pH 9.0).
The adsorption data of IDL-VLDL at 25 °C were acquired by
35 μL IDL-VLDL injections (3, 5, 10, 15, 20, 30, 35, 40, 50, 60,
70, 80, 90, 100, and 110 μg/mL) on the amine coupled chip at
the flow rate of 50 μL/min using phosphate buffer (pH 7.4) as
the running buffer. Blank injections were performed prior every
analyte injection, see Figure S2 in the Supporting Information.
Following dissociation for 500 s, the surface was regenerated
with a 0.28 M ammonium hydroxide (pH 11.5) and re-
equilibrated with running buffer. Running buffer was prepared
as described in ref 27.
PTH1R Assay. PTH1R was amine coupled to a LNB-
carboxyl chip using the manufacturer’s amine coupling kit and
protocol (Attana AB, Stockholm, Sweden). The coupling was
done according to the description for the HER2 assay above.
With the exception that 50 μL of PTH1R (10 μg/mL in 10
mM acetic acid, pH 4.5) was injected over the activated surface
at a flow rate of 10 μL/min. The frequency change was typically
Figure 2. (a) Sensorgrams for a trastuzumab-HER2 system at different analyte concentration levels. (b) Dissociation graph for a 172 nM injection.
(c) Rate Constants Distribution (RCD) for a 14 nM injection. (d) Rate constants obtained by fitting a two interactions model to the sensorgrams
one by one. See Figure 1 for more details and the Supporting Information Table S2 for rate constants.
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between 20 and 30 Hz. Finally, free carboxyl groups were
blocked by a 50 μL injection of 1 M ethanolamine pH 8.5.
The adsorption of PTH at 20 °C were acquired by 35 μL of
PTH injections (4, 5, 6, 8, 10, 12, 14, 17, and 20 μg/mL) at a
flow rate of 25 μL/min, following dissociation for 510 s. Blank
injections were performed prior to every analyte injection, see
Figure S3 in the Supporting Information. As a running buffer,
10 mM HEPES with 150 mM NaCl and 0.005% Tween-20, pH
7.4 was used.
Calculations. The time when the injection begins, t0, was
estimated directly from the measured sensorgrams individually
by an algorithm based on fitting concavity constrained Hermite
polynomials to the association phase. The RCDs were
calculated using adaptive Finite Element triangulation.25 For
fitting to the kinetic model, we used a combination of a global
Genetic Algorithm and a nonlinear least-squares solver. The
Genetic Algorithm was the MATLAB,29 Global Optimization
Toolbox function “ga” with the fitness function set to the
residual norm, the population size set to 5000, and the number
of generations set to 100. The Genetic Algorithm was run in
parallel on a computer cluster with 20 calculation cores (Intel
Core i7-3770S 3.10 GHz). The nonlinear least-squares solver
was the trust region reflective algorithm,30 “lsqnonlin” in
MATLAB,29 and Optimization Toolbox with the initial guess
set to the parameters found by the Genetic Algorithm.
■ RESULTS AND DISCUSSION
A new four-step strategy is used here to analyze the sensor data.
The new strategy is based on a recently published improved
algorithm25 for fast and reliable calculations of Rate Constant
Distributions (RCDs) from sensorgrams. An RCD is a two-
dimensional distribution of association and dissociation rate
constants, which will display heterogeneous data as a map
where each local distribution observed in the map corresponds
to one interaction, see Figure 1c.
The four-step strategy will be used, evaluated, and compared
with the conventional approach, i.e., global fitting of all
sensorgrams simultaneously.12,13 The evaluation will be carried
out on synthetic (see Figure 1a) and on three experimental
biosensor (QCM) data sets representing different kinetics (see
Figures 2−4).
Proposed Strategy for Rate Constant Estimation. The
suggested four-step strategy for more reliable processing of
complex binding kinetics consists of the following four steps
(see also Figure 1):
(1) Plot a dissociation graph (cf. Figure 1b) to get the first
impression of the data under investigation. If the plot is linear,
there is just one interaction and one can move directly to step
(3), otherwise continue to step (2).
(2) Calculate RCDs for each sensorgram separately (cf.
Figure 1c) to estimate the number of interactions.
Figure 3. (a) Sensorgrams for an IDL-VLDL-anti-apoB-100 system at different analyte concentration levels. (b) Dissociation graph for a 215 nM
injection. (c) Rate Constants Distribution (RCD) for a 20 nM injection. (d) Rate constants obtained by fitting a two interactions model to the
sensorgrams one by one. See Figure 1 for more details and the Supporting Information Table S3 for rate constants.
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(3) Do fitting to the sensorgrams one by one using the
number of interactions determined in step (2).
(4) Plot the determined rate constants, remove outliers, and
do clustering of all rate constants estimated from step (3), (cf.
Figure 1d).
The simplest way to cluster the data is to set manually rough
cluster center points and then assign the rate constant pairs
based on their distance to the cluster center points. Another
strategy is to use statistical clustering tools such as hierarchical
clustering or k-means.31 It should be noted that in this strategy,
in contrast to the conventional global fitting method, there is
no need to exclude sensorgrams for potentially failed injections
in the analysis. Those can be easily detected as outliers in step
(4) and removed at that stage.
In the following subsections, we will evaluate the four-step
strategy on synthetic data sets (Figure 1) as well as three
different biosensor (QCM) assays representing slow kinetics
(Figure 2), medium-slow kinetics (Figure 3), and fast kinetics
(Figure 4) systems.
The Supporting Information contains complementary
information, such as model fits and residual plots, obtained
by the new strategy and the conventional global fitting
approach.
Synthetic Data. In this section we are going to analyze the
new strategy using synthetic two interactions data with rate
parameters log10(ka,1) = 6.00 (M s)
−1, log10(kd,1) = −2.50 s−1,
log10(ka,2) = 4.50 (M s)
−1, log10(kd,2) = −1.50 s−1, and Rmax,1 =
100.0 RU, Rmax,2 = 500.0 RU. The new strategy is compared to
conventional global fitting using both ideal synthetic data and
synthetic data for a deteriorating system.
First, we test an ideal system, the sensorgrams at different
analyte concentrations can be found in the Supporting
Information Figure S4a. The corresponding dissociation
graph in Figure S4b indicates that at least two interactions
are needed to describe the system. In Figure S4c the RCDs
demonstrate that we have two interactions, and Figure S4d
shows the clustered rate constants estimated by fitting to the
sensorgrams one by one using a two interactions kinetic model.
The stars in Figure S4d are the estimated rate constants using a
conventional global fit routine and the crosses indicate median
rate constants for the clusters. In this case they coincide,
meaning that global fitting and the new strategy give the same
results.
It is not uncommon for experimental systems to slowly
deteriorate, i.e., lose signal. There might be several reasons for
this, e.g., some ligand molecules are destroyed or washed out in
the regeneration step of the biosensor chip. This is simulated in
Figure 1a by using the same system as above (vertical line
indicates end of injection) but setting Rmax to 95% of the value
in the previous injection. A common reaction would be to
consider the experiment failed and discard the data set, then
redo the experiment with a fresh chip, new buffers etc.; a time-
consuming and costly procedure without any guarantee that the
data will improve. However, here we will try to process the data
Figure 4. (a) Sensorgrams for a PTH-PTH1R system at different analyte concentration levels. (b) Dissociation graph for a 7 286 nM injection. (c)
Rate Constants Distribution (RCD) for a 4129 nM injection. (d) Rate constants obtained by fitting a two interactions model to the sensorgrams one
by one. See Figure 1 for more details and the Supporting Information Table S4 for rate constants.
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using our four-step strategy. In Figure 1d the estimated
clustered rate constants from the new strategy, median values
indicated by crosses are seen together with the result from
conventional global fitting, indicated by stars. In this case, the
new strategy provided excellent results but the conventional
global fitting gave large errors, especially for the second
association rate constant where the correct value is 4.50 but
global fitting estimated it to 6.17, see also Figure S5 and Table
S1. This is because the conventional global fitting method does
not handle deteriorating systems well. The problem was solved
using our new strategy, where fitting to the sensorgrams is done
one by one.
High Affinity Complex. The interaction between human
epidermal growth factor receptor 2 (HER2) and trastuzumab
that forms a high affinity complex was studied at 35 °C.
Trastuzumab, sold under the brand name Herceptin among
others, is a monoclonal antibody used to treat breast cancer
that is HER2 receptor positive.
The measured sensorgrams are presented in Figure 2a. From
the sensorgrams it is clear that the dissociation (i.e., after the
vertical line in the figure) was very slow. However, it is hard to
deduce directly from the sensorgrams if the data originates
from a single interaction or many interactions. The dissociation
graph can be used to indicate potential heterogeneity, see
Figure 2b for the 172 nM trastuzumab experiment. The graph
is only slightly convex indicating that the interaction could be
heterogeneous. Using the new strategy, we calculated the RCDs
for all sensorgrams to estimate how many different interactions
are needed to accurately describe the total response for the
system, see Figure 2c for the RCD for a 14 nM injection. From
the RCDs we can identify a major interaction at log10(ka) ≈ 5.5,
log10(kd) ≈ −4 as well as a minor interaction at log10(ka) ≈ 3,
log10(kd) ≈ −1.5. Because of this observation, the sensorgrams
were fitted to a two-site model one by one. In Figure 2d the
clustered estimated rate constants are presented. The sizes of
the circle areas are proportional to the interactions contribution
to the total response, i.e., the larger the circle area the more the
interaction contributes to the total response. Inspecting the
estimated rate constants, we can identify two different clusters,
corresponding to the major and minor interaction in the RCD,
see Figure 2c. The estimated rate constants for the minor
interactions are much more scattered compared to the major
interactions. Minor interaction contributes very little to the
overall response and is therefore very sensitive to system noise.
We compared simultaneously the result above with conven-
tional global fitting to all sensorgrams; using one- and two-
interaction model see Figure S6 and Table S2, respectively. As
expected, we see that the fit becomes better if a two interactions
model is used. However, this does not necessarily prove it to be
more appropriate as the estimated dissociation rate constant for
the first interaction is unrealistically small (log10kd = −21.2) and
has extremely large error bounds. Therefore, the conclusion
from global fitting is that it is probably more appropriate to use
a single interaction model. For this interaction we get similar
results from the new strategy and global fitting, log10 KD =
−9.42 and log10KD = −9.18 respectively.
The advantage of using the new strategy was that we could
observe that at least two interactions are necessary to give
accurate description for the system. We also successfully
resolved two different interactions using the new strategy,
whereas the conventional global fitting was only able to resolve
one, since the two interactions model gave an unrealistic
dissociation constant.
Medium High Affinity Complex. The interaction of
VLDL and IDL with anti-apoB-100 monoclonal antibody at 25
°C was investigated. VLDLs and IDLs are involved in
conversion to Low-Density Lipoprotein (LDL),32 that is
responsible for initiation of atherosclerosis.33 Since these
lipoproteins contain apolipoprotein B-100 (apoB-100), anti-
apoB-100 Mab can be used to study IDL-VLDL mixture
interactions.
From the sensorgrams of Figure 3a it is clear that the
dissociation (after the vertical line in the figure) was moderately
slow. To analyze the heterogeneity, dissociation graphs in
Figure 3b for the 215 nM IDL-VLDL-anti-apoB-100 experi-
ment, was plotted. The graphs are slightly convex, indicating
that the interaction could be heterogeneous. From the RCD for
the 20 nM injection (Figure 3c) we can identify two different
interactions both with log10(ka) ≈ 5.5 and with log10(kd) ≈ −4,
log10(kd) ≈ −1.5. We therefore fitted a two-site model to all
sensorgrams one by one. From the estimated rate constants,
seen in Figure 3d, two distinct clusters can be identified. The
first at log10(kd) ≈ −3.1, log10(ka) ≈ 5.8, with a small cluster
distribution, and the second at log10(kd) ≈ −1.4, log10(ka) ≈
3.6, with a broader cluster distribution.
By inspecting the data, we see that the experimental system is
deteriorating in a similar way as the synthetic data in Figure 1a.
We can therefore suspect that global fitting might give
erroneous rate constant estimation. To compare the result
with the conventional way of analyzing the data, all the sensor
data was simultaneously fitted to one- and two- interactions
model, see Figure S7 and Table S3. Here the results are almost
the same as for the new strategy for the first interaction.
However, if a two interactions model was used, the results for
the second interactions deviate strongly, giving log10(ka) 3.57
with the new strategy and 6.09 using global fitting, see Table
S3. This is because the conventional global fitting procedure is
not able to handle deteriorating systems.
Analyzing the global fitting result is tricky in this case. First,
the dissociation graph is only slightly convex indicating that a
linear model could probably describe the data rather well.
Second, the improvement in model fit from one- to two-
interactions model is modest. However, the second site
contribution to the total response is non-negligible, about
7%, so probably a two-site model is more appropriate.
The advantage of using the new strategy in this case is that
we could, from the local RCD, conclude that two interactions
are needed to describe the system. In addition, there were no
problem with the deteriorating system as was the case with
global fitting. Moreover, the interpretation of the global fitting
results was not as straightforward. From the results it can be
easily concluded that the system fits one interaction model,
since only minor improvement was achieved with the two
interaction model.
Low Affinity Complex. Parathyroid hormone (PTH)-
Parathyroid Hormone Receptor (PTH1R) interaction at 20 °C
was investigated. PTH is a hormone secreted by the
parathyroid glands (84 amino acid long). PTH is important
in bone remodeling by regulating the blood calcium cation
concentration.34 In this study, synthetic PTH and PTH1R
containing only the first 34 amino acids was used. However, the
in vivo and in vitro activities of synthetic PTH compared to
natural one have been shown to be similar.35
From the sensorgrams of Figure 4a it is evident that the
dissociation (after the vertical line in the figure) is fast.
Observing the association phase, we see that we probably have
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a fast association and a slow association, indicating that the
interaction is heterogeneous. To investigate this in more detail,
we plotted the dissociation graph, see Figure 4b for the 7286
nM PTH injection. The graph is strongly convex, indicating
clearly that the interaction is heterogeneous. In Figure 4c, the
RCD for the 4129 nM PTH experiment demonstrates two
distributions with the same log10(ka) ≈ 4 and with log10(kd) ≈
−2, log10(kd) ≈ −1. We therefore fitted a two-site model to all
sensorgrams one by one. From Figure 4d, the estimated rate
constants can be seen and two distinct clusters could be
identified. The first at log10(kd) ≈ −0.9, log10(ka) ≈ 4.2, with a
small cluster distribution, and the second at log10(kd) ≈ −2.3,
log10(ka) ≈ 3.7, with a broader cluster distribution.
To compare the data achieved with the conventional
approach, the sensorgrams were simultaneously fitted to one-
and two- interactions model, see Table S4. In this case, the data
fitted much better to two- interactions model (RMSEN 7.3%)
compared to one- interaction model (RMSEN 14.1%). The
errors in the predicted rate constants for the two-interactions
model are also small indicating that a good fit was found.
In this case, the new strategy (crosses in Figure 4d) and
global fitting (stars in Figure 4d) gave more or less the same
predicted rate constants and equilibrium constant. However,
although global fitting worked in this case, the new strategy is
more robust and can handle cases where global fitting fails.
Thus, from a practical point of view the new strategy is
preferred.
■ CONCLUSIONS
It is important that the recent technological development in the
biosensor area is accompanied by a corresponding development
in the processing of the kinetic data. To meet this requirement,
we suggest the new four-step strategy for the reliable estimation
of the rate constants from sensorgram data.
The four-step strategy is based on our new fast Adaptive
Interaction Distribution Algorithm (AIDA). The first step is to
plot dissociation graphs in order to get an indication of the
heterogeneity of the data, i.e., if one or several interactions are
present in the system. In the second step, whenever needed, the
Rate Constant Distributions for each sensorgram are calculated
with AIDA25 in order to estimate the number of interactions for
an accurate representation of the system. In the third step,
fitting is done to the sensorgrams, one by one, using a kinetic
model with the number of interactions estimated in the second
step. In the fourth and final step, the rate constants determined
are clustered, and each cluster describes an interaction present
in the system.
The new four-step strategy was evaluated and compared with
the conventional method, i.e., global fitting to all sensorgrams
simultaneously.12,13 The evaluation was first done using
synthetic data, where the true rate constants were known. In
order to test the ability of the new strategy to handle
experimental noise and other experimental disturbances, the
strategy was tested on three experimental biosensor (QCM)
assays with slow, moderate, and fast kinetics.
The new four-step strategy was found to be particularly
useful when processing complex data and data from
deteriorating systems, whereas for simple and stable systems,
conventional global fitting worked as well. However, since it is
difficult to predict when a system is simple enough to suit to
the conventional approach, we recommend that the new four-
step approach is preferred. This four-step approach is applicable
for any instrumental platform, not only for QCM based
biosensors but also for SPR biosensors.
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